Takeda Pharmaceutical Li... (TKPHF)

PNK: TKPHF · Real-Time Price · USD

29.85

-2.28 (-7.10%)

At close: Apr 30, 2025, 3:48 PM

Takeda Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	1,144.1B	1,176B	1,208B	1,050.9B	1,111.2B	1,043.1B	1,058.6B	956.16B	1,096.6B	1,002.3B	972.47B	873.29B	901.29B	844.82B	949.6B	770.27B	836.75B	788.93B	801.85B	771.7B	859.32B	811.05B	849.12B	717.21B	499.4B	430.78B	449.83B	400.96B	488.15B	433.18B	448.24B	416.2B	465.05B	416.8B	434B	414.12B	489.21B	457.75B	446.3B
Cost of Revenue	416.87B	394.31B	549.78B	382.5B	379.48B	343.58B	321.11B	309.77B	335.97B	305.44B	292.88B	308.38B	281.4B	275.8B	241.26B	253.45B	253.14B	249.64B	238.08B	248.18B	279.57B	271.71B	300.59B	289.83B	138.51B	110.75B	120.59B	110.89B	142.29B	121.87B	120.87B	134.41B	147.49B	141.46B	135.4B	132.97B	145.03B	136.29B	121.12B
Gross Profit	727.25B	781.73B	658.21B	668.37B	731.71B	699.51B	737.5B	646.38B	760.58B	696.86B	679.58B	564.91B	619.89B	569.02B	708.34B	516.83B	583.61B	539.29B	563.77B	523.52B	579.74B	539.34B	548.53B	427.38B	360.89B	320.03B	329.24B	290.07B	345.86B	311.3B	327.37B	281.8B	317.56B	275.33B	298.61B	281.16B	344.18B	321.46B	325.17B
Operating Income	66.94B	184.25B	166.33B	187.28B	104.91B	-49.34B	168.57B	88.56B	146.99B	104.44B	150.51B	-1.62B	116.48B	97.43B	248.55B	150.54B	143.14B	48.3B	167.28B	-62.14B	53.51B	40.44B	9.87B	-79.45B	112.46B	73.09B	98.87B	-80.5B	87.94B	39.37B	194.97B	-61.56B	55.35B	9.14B	152.93B	-36.65B	57.03B	60.89B	49.56B
Interest Income	-6.99B	4.12B	30.68B	5.99B	21.79B	9.36B	26.45B	7.78B	41.68B	14.78B	60.92B	n/a	4.14B	6.86B	45.85B	47.49B	28.4B	10.02B	19.61B	n/a	34.2B	8.7B	8.67B	n/a	5.4B	2.47B	6.23B	17.84B	7.59B	619M	13.5B	3.5B	3.86B	2.44B	2.48B	4.38B	4.32B	8.79B	4.15B
Pretax Income	26.41B	119.37B	136.6B	-51.26B	61.26B	-95.98B	135.03B	47.91B	107.15B	64.55B	155.47B	-54.05B	72.19B	61.45B	222.98B	130.88B	109.8B	-4.73B	130.29B	-116.76B	24.84B	-2.37B	-25.19B	-113.48B	47.6B	66.92B	93.86B	-70.69B	54.9B	34.75B	198.24B	-65.47B	53.8B	5.34B	149.68B	-34.07B	52.57B	53.32B	48.72B
Net Income	23.79B	92.05B	95.25B	-3.02B	105.72B	-48.03B	89.39B	31.13B	119.13B	61.74B	105.01B	-11.36B	57.77B	45.96B	137.68B	197.1B	92.36B	4.04B	82.51B	1.72B	-32.22B	53.84B	-20.66B	-55.31B	37.77B	48.43B	78.24B	-54.02B	68.09B	28.03B	144.79B	-50.73B	41.37B	24.77B	99.53B	-33.48B	59.26B	29.8B	24.58B
Selling & General & Admin	270.59B	268.28B	270.03B	285.23B	267.52B	252.95B	248.11B	254.8B	262.3B	248.73B	231.48B	223.43B	231.08B	212.01B	219.84B	234.39B	222.64B	216.26B	202.37B	253.06B	249.21B	223.26B	239.21B	269.92B	153.89B	148.75B	145.03B	171.77B	159.08B	151.4B	145.87B	179.69B	148.43B	145.98B	144.96B	175.25B	162.03B	151.8B	161.69B
Research & Development	170.19B	175.56B	168.46B	195.86B	187.38B	183.95B	162.74B	160.94B	174.63B	154.15B	143.61B	143.63B	128.38B	131.6B	122.48B	113.29B	117.57B	118.16B	106.82B	139.31B	122.71B	113.5B	116.87B	139.41B	77.46B	79.47B	71.97B	88.78B	81.56B	79.41B	75.69B	88.5B	71.83B	75.42B	76.55B	92.03B	92.53B	80.38B	80.99B
Other Expenses	219.53B	153.63B	216.21B	n/a	-1.21B	n/a	n/a	n/a	-1.01B	n/a	n/a	n/a	n/a	-1.52B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	660.31B	597.48B	654.71B	481.09B	665.29B	748.85B	568.93B	557.82B	613.59B	592.42B	529.07B	566.53B	503.4B	471.6B	459.79B	366.29B	440.47B	490.99B	396.49B	585.66B	526.23B	498.89B	538.66B	551.43B	248.42B	246.94B	230.37B	370.57B	257.93B	271.93B	132.4B	343.36B	262.2B	266.19B	145.68B	317.81B	287.15B	260.57B	275.62B
Interest Expense	31.6B	68.45B	59.69B	47.19B	66.57B	46.52B	59.58B	42.93B	79.75B	53.8B	55.47B	n/a	46.71B	39.68B	71.07B	75.24B	62.67B	63.87B	46.85B	60.93B	43.74B	53.2B	46.06B	24.94B	22.27B	9.11B	14.79B	9.17B	6.78B	6.02B	9.96B	6.24B	5.89B	5.75B	5.37B	1.35B	8.26B	16.52B	5.8B
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	121.06B	n/a	n/a	n/a
Cost & Expenses	1,077.2B	991.79B	1,041.7B	863.59B	1,044.8B	1,092.4B	890.05B	867.59B	949.56B	897.87B	821.95B	874.91B	784.81B	747.39B	701.05B	619.73B	693.61B	740.63B	634.57B	833.84B	805.81B	770.6B	839.25B	841.27B	386.94B	357.69B	350.96B	481.46B	400.21B	393.8B	253.26B	477.77B	409.69B	407.65B	281.07B	450.77B	432.18B	396.86B	396.74B
Income Tax Expense	2.57B	27.27B	41.3B	-44.53B	-44.5B	-48.01B	45.63B	16.78B	-12B	2.82B	50.45B	-42.67B	14.37B	15.45B	85.25B	-66.27B	17.36B	-8.8B	47.77B	-118.32B	56.95B	-56.29B	-4.55B	-58.14B	9.73B	18.51B	15.78B	-16.7B	-13.12B	7.07B	53.25B	-12.95B	11.37B	-19.92B	49.33B	-1.18B	-7.81B	22.76B	23.29B
Shares Outstanding (Basic)	1.58B	1.58B	1.59B	1.57B	1.57B	1.57B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.57B	1.57B	1.55B	1.57B	1.56B	1.56B	1.56B	1.57B	1.56B	1.56B	1.55B	1.5B	784.48M	784.44M	782M	781.23M	781.11M	780.94M	780.07M	780M	780.79M	780.99M	781.83M	779.04M	783.45M	783.44M	784.9M
Shares Outstanding (Diluted)	1.61B	1.61B	1.59B	1.57B	1.59B	1.57B	1.57B	1.61B	1.57B	1.56B	1.55B	1.55B	1.57B	1.58B	1.55B	1.57B	1.58B	1.57B	1.57B	1.57B	1.56B	1.56B	1.56B	1.5B	788.46M	787.68M	786.46M	781.23M	786.34M	785.76M	785.23M	780M	784.64M	783.71M	785.22M	779.07M	790.03M	790.29M	789.94M
EPS (Basic)	15.03	58.14	59.94	-1.92	67.38	-30.68	57.51	20.03	76.63	39.77	67.92	-7.31	36.91	29.24	89.08	125.19	59.08	2.58	52.93	1.10	-20.68	34.56	-13.29	-36.98	48.14	61.73	100.05	-69.15	87.17	35.89	185.61	-65.04	52.99	31.72	127.30	-42.98	75.64	38.04	31.32
EPS (Diluted)	14.78	57.17	59.94	-1.92	66.70	-30.68	57.12	19.29	75.86	39.48	67.56	-7.31	36.68	29.08	88.58	125.18	58.61	2.57	52.68	1.10	-20.68	34.47	-13.23	-36.98	47.90	61.48	99.49	-69.15	86.59	35.67	184.39	-65.04	52.73	31.61	126.75	-42.97	75.01	37.71	31.12
EBITDA	244.96B	380.28B	384.55B	86.09B	291.98B	133.35B	347.9B	252.26B	323.87B	272.26B	323.04B	121.3B	263.77B	238.07B	391.55B	126.99B	282.89B	187.25B	293.06B	54.02B	198.33B	288.55B	323.79B	49.3B	136.7B	112.5B	142.73B	-7.15B	135.5B	77.57B	254.13B	16.04B	96.56B	71.64B	196.74B	19.29B	107.41B	106.94B	98.52B
EBIT	58B	187.83B	196.29B	-100.65B	127.83B	-37.96B	194.61B	38.12B	186.9B	118.35B	210.94B	-75.15B	118.9B	101.12B	294.05B	54.12B	172.47B	59.14B	177.14B	-91.71B	68.58B	74.25B	56.18B	-106.84B	69.87B	76.03B	108.66B	-61.52B	87.94B	39.38B	208.21B	-59.23B	59.69B	11.09B	155.05B	-32.71B	60.83B	69.84B	54.52B
Depreciation & Amortization	186.96B	192.45B	192.22B	186.74B	187.06B	182.7B	171.5B	161.41B	176.88B	167.83B	158.28B	152.27B	147.28B	140.65B	142.95B	72.87B	139.75B	138.94B	141.59B	76.17B	144.82B	142.69B	150.41B	117.61B	38.33B	39.41B	38.56B	54.37B	43.57B	38.19B	46B	75.28B	41.21B	62.5B	43.8B	52B	50.38B	46.05B	48.96B